Intensity-modulated radiation therapy for prostate cancer: Late morbidity and results on biochemical control

This publication has 39 references indexed in Scilit:

• Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
  British Journal of Cancer, 2005
• The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: Feasibility and acute toxicity
  International Journal of Radiation Oncology*Biology*Physics, 2004
• Intensity-modulated radiotherapy as primary treatment for prostate cancer: Acute toxicity in 114 patients
  International Journal of Radiation Oncology*Biology*Physics, 2004
• The Incidence of Inclusion of the Sigmoid Colon and Small Bowel in the Planning Target Volume in Radiotherapy for Prostate Cancer
  Strahlentherapie und Onkologie, 2004
• Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era
  Cancer, 2002
• An anatomy-based beam segmentation tool for intensity-modulated radiation therapy and its application to head-and-neck cancer.
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
  New England Journal of Medicine, 1997
• Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of 4–20 ng/ml
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)
  International Journal of Radiation Oncology*Biology*Physics, 1995